Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,604 public trials 495 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Active, Not Recruiting

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

NCT04782687

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Maryland Oncology Hematology, P.A. Columbia, Maryland, United States
  • New York Oncology Hematology, P.C. Albany, New York, United States
View Trial Details
Active, Not Recruiting

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

NCT04096066

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AO "SS. Antonio e Biagio" Alessandria, Italy
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • Ospedale Mazzoni Ascoli Piceno, Italy
  • Policlinico di Bari Bari, Italy
View all 40 locations
View Trial Details
Active, Not Recruiting

A Study of Isatuximab Added to Standard CyBorD Induction and Lenalidomide Maintenance Treatments in ND-TEMM

NCT04786028

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Nova Scotia Health - QEII Health Sciences Centre Halifax, Nova Scotia, Canada
  • Hamilton Health Sciences Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital General Campus Ottawa, Ontario, Canada
View Trial Details
Active, Not Recruiting

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

NCT02315716

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Queen's Hospital Romford, Essex, United Kingdom
  • Royal United Hospital Bath, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • NHS Lanarkshire Bothwell, United Kingdom
View all 20 locations
View Trial Details
Active, Not Recruiting

Pomalidomide in Relapsed and Refractory Multiple Myeloma (RRMM)

NCT02406222

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University of Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, United Kingdom
  • Royal Sussex County Hospital Brighton, United Kingdom
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)

NCT03989414

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 119 Denver, Colorado, United States
  • Local Institution - 104 Tampa, Florida, United States
  • Local Institution - 108 Atlanta, Georgia, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 49 locations
View Trial Details

Related conditions